|
2007 Journal Article Impact of diabetes on the severity of liver diseaseHickman, I.J. and Macdonald, G.A. (2007). Impact of diabetes on the severity of liver disease. The American Journal of Medicine, 120 (10), 829-834. doi: 10.1016/j.amjmed.2007.03.025 |
|
2007 Journal Article Central obesity is common in renal transplant recipients and is associated with increased prevalence of cardiovascular risk factorsOrazio, Linda, Armstrong, Kirsty, Banks, Merrilyn, Johnson, David, Isbel, Nikky and Hickman, Ingrid (2007). Central obesity is common in renal transplant recipients and is associated with increased prevalence of cardiovascular risk factors. Nutrition & Dietetics, 64 (3), 200-206. doi: 10.1111/j.1747-0080.2007.00151.x |
|
2006 Journal Article Relative adrenal insufficiency in sepsis:match point or deuce?Venkatesh, B., Prins, J., Torpy, D., Chapman, M., Joyce, C., Cooper, D. J., Cohen, J., Hickman, I., Jones, D. and Higgins, A. (2006). Relative adrenal insufficiency in sepsis:match point or deuce?. Critical Care and Resuscitation, 8 (4), 376-380. doi: 10.1016/s1441-2772(23)02076-8 |
|
2006 Conference Publication Causes of raised liver enzymes in a diabetic clinicHickman, I. J., Russell, A. W. and Macdonald, G. A. (2006). Causes of raised liver enzymes in a diabetic clinic. Australian Gastroenterology Week, Adelaide, SA, Australia, 1–14 October 2006. Richmond, VIC, Australia: Wiley-Blackwell. |
|
2006 Journal Article Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: A potential mechanism for Olanzapine-induced insulin resistance in patients with schizophreniaRichards, A. A., Hickman, I. J., Wang, A. Y. H., Jones, A. L., Newell, F., Mowry, B. J., Whitehead, J. P., Prins, J. B. and Macdonald, G. A. (2006). Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: A potential mechanism for Olanzapine-induced insulin resistance in patients with schizophrenia. Journal of Clinical Psychopharmacology, 26 (3), 232-237. doi: 10.1097/01.jcp.0000218404.64619.52 |
|
2006 Journal Article Adiponectin – a key adipokine in the metabolic syndromeWhitehead, J. P., Richards, A. A., Hickman, I. J., Macdonald , G. A. and Prins, J. B. (2006). Adiponectin – a key adipokine in the metabolic syndrome. Diabetes, Obesity and Metabolism, 8 (3), 264-280. doi: 10.1111/j.1463-1326.2005.00510.x |
|
2005 Journal Article Adiponectin and its receptors in patients with chronic hepatitis CJonsson, JR, Moschen, AR, Hickman, IJ, Richardson, MM, Kaser, S, Clouston, AD, Powell, EE and Tilg, H (2005). Adiponectin and its receptors in patients with chronic hepatitis C. Journal of Hepatology, 43 (6), 929-936. doi: 10.1016/j.jhep.2005.05.030 |
|
2005 Conference Publication Presence of the metabolic syndrome is associated with reduced adiponectin levels and liver dysfunction in patients with type 2 diabetesHickman, Ingrid J., Prins, Johannes B., Whitehead, Jonathon P. and Macdonald, Graeme A. (2005). Presence of the metabolic syndrome is associated with reduced adiponectin levels and liver dysfunction in patients with type 2 diabetes. 56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases,, San Francisco, CA, 11-15 November, 2005. Hoboken, NJ: Wiley Interscience. doi: 10.1002/hep.20927 |
|
2005 Journal Article High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3, but not genotype 1 infectionWang, Amy Y-H., Hickman, Ingrid J., Richards, Ayanthi A., Whitehead, Jonathan P., Prins, Johannes B. and Macdonald, Graeme A. (2005). High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3, but not genotype 1 infection. American Journal of Gastroenterology, 100 (12), 2717-2723. doi: 10.1111/j.1572-0241.2005.00311.x |
|
2004 Other Outputs The role of obesity in the development and progression of chronic liver diseasesHickman, Ingrid Joy (2004). The role of obesity in the development and progression of chronic liver diseases. PhD Thesis, School of Medicine, The University of Queensland. |
|
2004 Journal Article Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of lifeHickman, IJ, Jonsson, JR, Prins, JB, Ash, S, Purdie, DM, Clouston, AD and Powell, EE (2004). Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut, 53 (3), 413-419. doi: 10.1136/gut.2003.027581 |
|
2003 Journal Article In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapyHickman, I. J., Powell, E. E., Prins, J. B., Clouston, A. D., Ash, S., Purdie, D. M. and Jonsson, J. R. (2003). In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. Journal of Hepatology, 39 (6), 1042-1048. doi: 10.1016/S0168-8278(03)00463-X |
|
2003 Journal Article Fatty liver disease: The next epidemic?Hickman, Ingrid and Powell, Elizabeth (2003). Fatty liver disease: The next epidemic?. Medicine Today, 4 (2), 40-47. |
|
2003 Conference Publication Benefit of sustained weight loss and exercise in overweight patients with liver disease - Indicators for successHickman, I. J., Jonsson, J. R., Prins, J. B., Ash, S., Purdie, D. M., Clouston, A. D. and Powell, E. E. (2003). Benefit of sustained weight loss and exercise in overweight patients with liver disease - Indicators for success. 54th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, Boston, MA, United States, 24-28 October 2003. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/hep.1840380507 |
|
2002 Journal Article Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis CHickman, I. J., Clouston, A. D.., Macdonald, G. A., Purdie, D. M., Prins, J. B., Ash, S., Jonsson, J. R. and Powell, E. E. (2002). Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut, 51 (1), 89-94. doi: 10.1136/gut.51.1.89 |
|
2002 Conference Publication Fibrosis in chronic hepatitis C correlates significantly with circulating insulin levelsHickman, Ingrid, Powell, Elizabeth, Clouston, Andrew, Ash, Susan, Pandaya, Nirmala, Purdie, David and Jonsson, Julie (2002). Fibrosis in chronic hepatitis C correlates significantly with circulating insulin levels. *, *, *. Amsterdam, Netherlands: Elsevier. doi: 10.1016/S0168-8278(02)80611-0 |
|
2002 Journal Article Residential camps as a setting for nutrition education of Australian girlsPayne J., Capra S. and Hickman I. (2002). Residential camps as a setting for nutrition education of Australian girls. Australian and New Zealand Journal of Public Health, 26 (4), 383-388. doi: 10.1111/j.1467-842X.2002.tb00191.x |
|
2002 Conference Publication Weight reduction in patients with chronic HCV reduces circulating insulin levelsHickman, Ingrid, Clouston, Andrew, Macdonald, Graeme, Ash, Susan, Prins, John, Purdie, David, Jonsson, Julie and Powell, Elizabeth (2002). Weight reduction in patients with chronic HCV reduces circulating insulin levels. -, Milan, Italy, April 18th, 2002. Ireland Ltd.: Elsevier Science. doi: 10.1016/S0168-8278(02)80921-7 |
|
2002 Conference Publication Intensive dietary intervention improves weight maintenance in the management of non-alcoholic fatty liver diseaseHickman, I., Powell, E., Jonsson, J. and Ash, S. (2002). Intensive dietary intervention improves weight maintenance in the management of non-alcoholic fatty liver disease. -, -, -. AMSTERDAM: ELSEVIER SCIENCE BV. doi: 10.1016/S0168-8278(02)80922-9 |
|
2002 Conference Publication Fibrosis in chronic hepatitis C correlates significantly with circulating C-peptide and insulin levelsJonsson, J. R., Hickman, I. J., Clouston, A. D., Ash, S., Prins, J., Pandaya, N., Purdie, D. M. and Powell, E. E. (2002). Fibrosis in chronic hepatitis C correlates significantly with circulating C-peptide and insulin levels. 53rd Annual Meeting of the Association for the Study of Liver-Diseases (AASLD), Boston, M.A. USA, 01-05 November 2002. Hoboken, NJ United States: John Wiley and Sons. |
